Given these observations, the present study aims to evaluate the diagnostic utility of combining PSAD with MLR to improve PCa detection in patients presenting with PSA levels between 4.0 and 20.0 ng/mL. This evidence concerns the gene KLK3 and posterior cortical atrophy.